Clifford Swan Investment Counsel LLC Boosts Holdings in Dow Chemical (DWDP)

Clifford Swan Investment Counsel LLC raised its holdings in shares of Dow Chemical (NYSE:DWDP) by 14.7% during the first quarter, according to its most recent filing with the SEC. The firm owned 55,887 shares of the company’s stock after purchasing an additional 7,168 shares during the period. Clifford Swan Investment Counsel LLC’s holdings in Dow Chemical were worth $3,561,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of DWDP. Standard Life Aberdeen plc grew its position in shares of Dow Chemical by 516.5% in the 4th quarter. Standard Life Aberdeen plc now owns 6,733,832 shares of the company’s stock worth $480,192,000 after buying an additional 5,641,549 shares during the last quarter. Mackenzie Financial Corp purchased a new position in shares of Dow Chemical in the 4th quarter worth approximately $118,025,000. Amundi Pioneer Asset Management Inc. grew its position in shares of Dow Chemical by 110.8% in the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 2,281,347 shares of the company’s stock worth $162,478,000 after buying an additional 1,198,892 shares during the last quarter. BlackRock Inc. grew its position in shares of Dow Chemical by 0.7% in the 4th quarter. BlackRock Inc. now owns 156,234,472 shares of the company’s stock worth $11,127,020,000 after buying an additional 1,138,483 shares during the last quarter. Finally, Huntington National Bank purchased a new position in shares of Dow Chemical in the 4th quarter worth approximately $69,208,000. 69.54% of the stock is currently owned by institutional investors and hedge funds.

Shares of Dow Chemical opened at $67.04 on Thursday, according to MarketBeat.com. The company has a quick ratio of 1.21, a current ratio of 1.87 and a debt-to-equity ratio of 0.29. Dow Chemical has a 12 month low of $60.38 and a 12 month high of $77.08. The company has a market cap of $157.14 billion, a price-to-earnings ratio of 19.72, a price-to-earnings-growth ratio of 1.70 and a beta of 1.30.

Dow Chemical (NYSE:DWDP) last announced its quarterly earnings data on Thursday, May 3rd. The company reported $1.12 EPS for the quarter, beating the consensus estimate of $1.08 by $0.04. Dow Chemical had a net margin of 2.37% and a return on equity of 8.01%. The business had revenue of $21.51 billion during the quarter, compared to analysts’ expectations of $21.31 billion. The firm’s revenue was up 62.6% on a year-over-year basis. equities research analysts forecast that Dow Chemical will post 4.19 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 15th. Shareholders of record on Thursday, May 31st will be paid a dividend of $0.38 per share. This represents a $1.52 annualized dividend and a yield of 2.27%. The ex-dividend date is Wednesday, May 30th. Dow Chemical’s payout ratio is 44.71%.

In other Dow Chemical news, insider Ronald C. Edmonds sold 15,000 shares of Dow Chemical stock in a transaction that occurred on Friday, March 9th. The shares were sold at an average price of $71.83, for a total transaction of $1,077,450.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Charles J. Kalil sold 69,400 shares of Dow Chemical stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $72.66, for a total transaction of $5,042,604.00. The disclosure for this sale can be found here. Insiders own 0.42% of the company’s stock.

A number of research analysts have recently issued reports on DWDP shares. Citigroup cut their price objective on shares of Dow Chemical from $83.00 to $82.00 and set a “buy” rating on the stock in a research report on Tuesday, April 10th. Credit Suisse Group cut their price objective on shares of Dow Chemical from $82.00 to $78.00 and set an “outperform” rating on the stock in a research report on Friday, May 4th. Zacks Investment Research raised shares of Dow Chemical from a “hold” rating to a “buy” rating and set a $85.00 price objective on the stock in a research report on Tuesday, January 30th. BMO Capital Markets started coverage on shares of Dow Chemical in a research report on Tuesday, March 27th. They issued an “outperform” rating and a $82.00 price objective on the stock. Finally, Morgan Stanley set a $80.00 price objective on shares of Dow Chemical and gave the stock a “buy” rating in a research report on Wednesday, March 21st. Six investment analysts have rated the stock with a hold rating and twenty-three have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $81.13.

About Dow Chemical

DowDuPont Inc, through its subsidiaries, engages in agriculture, materials science, and specialty products businesses worldwide. The company's Agriculture segment develops and sells hybrid corn seed and soybean seed varieties; canola, cotton, sunflower, sorghum, wheat, and rice seeds; silage inoculants; and weed control, disease control, and insect control products.

Institutional Ownership by Quarter for Dow Chemical (NYSE:DWDP)

Receive News & Ratings for Dow Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dow Chemical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply